<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: To assess the diagnostic potential of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated high molecular weight DNA in stool samples of 32 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients compared to 32 healthy Malaysian volunteers by means of polymerase chain reaction (PCR) </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Stool DNA was isolated and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e>-associated high molecular weight DNA (1.476 kb fragment including exons 6-9 of the p53 gene) was amplified using PCR and visualized on <z:chebi fb="0" ids="4883">ethidium bromide</z:chebi>-stained <z:chebi fb="2" ids="2511">agarose</z:chebi> gels </plain></SENT>
<SENT sid="2" pm="."><plain>RESULTS: Out of 32 CRC patients, 18 were positive for the presence of high molecular weight DNA as compared to none of the healthy individuals, resulting in an overall sensitivity of 56.3% with 100% specificity </plain></SENT>
<SENT sid="3" pm="."><plain>Out of 32 patients, 23 had <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> on the left side and 9 on the right side, 16 and 2 being respectively positive </plain></SENT>
<SENT sid="4" pm="."><plain>This showed that high molecular weight DNA was significantly (p=0.022) more detectable in patients with left side <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> (69.6% vs 22.2%) </plain></SENT>
<SENT sid="5" pm="."><plain>Out of 32 patients, 22 had <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> larger than 1.0 cm, 18 of these (81.8%) being positive for long DNA as compared to not a single patient with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size smaller than 1.0 cm (p&lt;0.001) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: We detected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-related high molecular weight p53 DNA in stool samples of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> patients with an overall sensitivity of 56.3% with 100% specificity, with a strong <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size dependence </plain></SENT>
</text></document>